Trodusquemine Terminated Phase 1 Trials for Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02524951Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer